Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.

Patients colonized with AMR pathogens showed high risk for infection with the same pathogen for up to 2 years, indicating a time window for decolonization interventions.

Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.

The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.

Exposure to cold in the Netherlands and to heat in Spain appears to be associated with more psychiatric symptoms among adolescents.

Heat-related deaths are expected to climb throughout Europe this century due to climate change, according to study findings.

Distribution of prescribed opioid analgesics is lower in majority non-White vs majority White communities across all levels of socioeconomic deprivation.

In COPD, muscular atrophy is a significant risk factor for death and may prolong patients’ hospital length of stay.

Respiratory illnesses that progress to pediatric asthma exacerbations are linked to a steeper rise in interferon expression in airways and blood.

Substantial gaps in COVID-19 vaccination were identified among people who inject drugs in San Francisco, California in 2022.

Children with COVID-19 vs RSV or influenza infections are at an increased risk of developing cardiovascular complications.

A few baseline characteristics can predict the need for recurrent endoscopic sinus surgery among patients with CRSwNP.